Brief: Parenteral Drugs India Sept-Qtr Loss Widens
Dec 14 (Reuters) - Parenteral Drugs India Ltd PADG.NS :
* SEPT QUARTER LOSS 227.1 MILLION RUPEES VERSUS LOSS 215
MILLION
RUPEES YEAR AGO
* SEPT QUARTER REVENUE FROM OPERATIONS 108.2 MILLION RUPEES
VERSUS 175.9 MILLION RUPEES YEAR AGO
Source text for Eikon: ID:nBSEFnHhN
Further company coverage: PADG.NS
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Parenteral Drugs (India)
See all newsBrief: Parenteral Drugs (India) Ops Remain Closed Due To Labour Unrest
Vinod Kumar Gupta Reappointed MD
Brief: Parenteral Drugs India Gets Shareholders' Nod For Sale Of Shares In Infutec Healthcare
Brief: Parenteral Drugs India Seeks Shareholders' Nod To Transfer Kasrawad, WFI Undertaking
Brief: Parenteral Drugs India To Consider Sale Of Kasrawad Undertaking